Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Shoji T, Takatori E, Omi H, Kumagai S, Yoshizaki A, Yokoyama Y, Mizunuma H, Fujimoto T, Takano T, Yaegashi N, Tase T, Nakahara K, Kurachi H, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: tase t. Int J Gynecol Cancer. 2011 Jan;21(1):44-50. doi: 10.1097/IGC.0b013e3181ffbe9f. Int J Gynecol Cancer. 2011. PMID: 21330830 Clinical Trial.
Investigation of the clinicopathological features of fallopian tube malignancy.
Yokoyama Y, Futagami M, Fujimoto T, Terada Y, Takatori E, Sugiyama T, Otsuki T, Yaegashi N, Kojimahara T, Kurachi H, Nishiyama H, Fujimori K, Tase T, Mizunuma H. Yokoyama Y, et al. Among authors: tase t. Oncol Rep. 2013 Jul;30(1):79-84. doi: 10.3892/or.2013.2439. Epub 2013 Apr 30. Oncol Rep. 2013. PMID: 23633088
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.
Takano T, Otsuki T, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, Niikura H, Ito K, Yaegashi N, Yamada H, Tase T, Kagabu M, Shoji T, Sugiyama T, Sato N, Fujimoto T, Terada Y, Nakahara K, Kurachi H, Yokoyama Y, Mizunuma H, Soeda S, Nishiyama H, Matsumoto T, Sato S, Shimada M, Kigawa J. Takano T, et al. Among authors: tase t. Int J Clin Oncol. 2014 Dec;19(6):1052-8. doi: 10.1007/s10147-013-0658-y. Epub 2014 Jan 7. Int J Clin Oncol. 2014. PMID: 24395448 Clinical Trial.
Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit.
Otsuki A, Otsuki T, Tokunaga H, Niikura H, Nagase S, Sugiyama T, Toyoshima M, Utsunomiya H, Yokoyama Y, Mizunuma H, Sato N, Terada Y, Shoji T, Sugiyama T, Nakahara K, Ohta T, Yamada H, Tase T, Nishiyama H, Fujimori K, Takano T, Takahashi F, Watanabe Y, Yaegashi N. Otsuki A, et al. Among authors: tase t. Int J Clin Oncol. 2015 Jun;20(3):574-8. doi: 10.1007/s10147-014-0732-0. Epub 2014 Jul 18. Int J Clin Oncol. 2015. PMID: 25030547
Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.
Futagami M, Yokoyama Y, Iino K, Aoki M, Shoji T, Sugiyama T, Ariga H, Tokunaga H, Takano T, Watanabe Y, Yaegashi N, Jingu K, Sato N, Terada Y, Anbai A, Ohta T, Kurachi H, Kuroda Y, Nishiyama H, Fujimori K, Watanabe T, Sato H, Tase T, Wada H, Mizunuma H. Futagami M, et al. Among authors: tase t. Int J Clin Oncol. 2015 Oct;20(5):1005-11. doi: 10.1007/s10147-015-0803-x. Epub 2015 Feb 24. Int J Clin Oncol. 2015. PMID: 25708593
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Kagabu M, Shoji T, Murakami K, Omi H, Honda T, Miura F, Yokoyama Y, Tokunaga H, Takano T, Ohta T, Shimizu D, Sato N, Soeda S, Watanabe T, Yamada H, Mizunuma H, Yaegashi N, Nagase S, Tase T, Sugiyama T. Kagabu M, et al. Among authors: tase t. Int J Clin Oncol. 2016 Aug;21(4):735-740. doi: 10.1007/s10147-016-0946-4. Epub 2016 Jan 19. Int J Clin Oncol. 2016. PMID: 26782958
Clinical outcome and risk factors for recurrence in borderline ovarian tumours.
Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, Yamada H, Yaegashi N, Okamura K, Izutsu T, Sugiyama T, Tanaka T, Kurachi H, Sato A, Tase T, Mizunuma H. Yokoyama Y, et al. Among authors: tase t. Br J Cancer. 2006 Jun 5;94(11):1586-91. doi: 10.1038/sj.bjc.6603139. Br J Cancer. 2006. PMID: 16685277 Free PMC article.
52 results